SCHEMBL17673757

SCHEMBL17673757

Cn1ncc2ccc(-c3cc(Nc4ccc(-n5ccnn5)cc4)nc(N4CCOCC4)n3)cc21

nearest known ligand 0.48

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.48
▸ MAPK10 P53779 1/20 0.48
▸ PIK3CA P42336 17/20 0.46
▸ PIK3CG P48736 3/20 0.44
▸ PIK3CD O00329 3/20 0.43
▸ PIK3CB P42338 3/20 0.43
▸ MTOR P42345 1/20 0.43
▸ PI4KB Q9UBF8 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17673778 0.89 PIK3CA (0.48) PIK3CAPIK3CGPIK3CDPIK3CBMTOR
SCHEMBL17673786 0.87 PIK3CA (0.49) PIK3CAPIK3CGPIK3CDPIK3CBMTOR
SCHEMBL17673620 0.87 MAPT (0.46) MAPK10PIK3CAPIK3CGPIK3CDPIK3CB
SCHEMBL17677913 0.86 PIK3CA (0.55) PIK3CAPIK3CGPIK3CDPIK3CBMTOR
SCHEMBL17673766 0.86 PIK3CA (0.46) MAPK8MAPK10PIK3CAPIK3CGPIK3CD
SCHEMBL17677939 0.86 MAPT (0.47) MAPK8MAPK10PIK3CAPIK3CGPIK3CD
SCHEMBL17673781 0.85 MAPK10 (0.47) MAPK8MAPK10PIK3CAPIK3CGPIK3CD
SCHEMBL17673682 0.85 PIK3CA (0.50) PIK3CAPIK3CGPIK3CDPIK3CBMTOR
SCHEMBL17673842 0.85 LMNA (0.59) PIK3CAPIK3CGPIK3CDPIK3CBMTOR
SCHEMBL17673877 0.85 MAPK10 (0.50) MAPK8MAPK10PIK3CAPIK3CGPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3204009-A1 HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES BioMarin Pharmaceutical Inc. (US) 2017-08-16 — — EP disclosed
WO-2016057834-A9 HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES BIOMARIN PHARMACEUTICAL INC. (US) 2017-04-13 — — WO disclosed
WO-2016057834-A1 HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES BIOMARIN PHARMACEUTICAL INC. (US) 2016-04-14 — — WO disclosed
Send feedback